ProPhase Labs, Inc. SEC filings PRPH

ProPhase Labs, Inc. has 923 filings in SEC EDGAR's recent list, going back to Aug 13, 1996. Its latest annual report, Form 10-K, was filed on Jun 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (material agreement, new debt). The company's fiscal year ends on December 31.

ProPhase Labs, Inc. SEC filings
Form Description Filed Period
DEF 14A Proxy statement Oct 31, 2025 Oct 31, 2025
PRE 14A Preliminary proxy statement Oct 21, 2025 Oct 21, 2025
DEFA14A Additional proxy material Aug 19, 2025 —
DEF 14A Proxy statement Aug 15, 2025 Aug 15, 2025
PRE 14A Preliminary proxy statement Jul 28, 2025 Jul 28, 2025
DEF 14A Proxy statement Jun 23, 2025 Jun 23, 2025
DEF 14A Proxy statement May 15, 2024 May 15, 2024
DEF 14A Proxy statement Apr 27, 2023 Apr 27, 2023
DEF 14A Proxy statement Apr 13, 2022 Apr 13, 2022
DEF 14A Proxy statement Apr 16, 2021 Apr 16, 2021
DEF 14A Proxy statement Apr 16, 2020 Apr 16, 2020
DEF 14A Proxy statement Apr 19, 2019 Apr 18, 2019
DEF 14A Proxy statement Apr 19, 2018 Apr 18, 2018
DEF 14A Proxy statement Mar 23, 2018 Mar 23, 2018
PRE 14A Preliminary proxy statement Feb 28, 2018 Feb 28, 2018
DEF 14A Proxy statement Apr 20, 2017 Apr 20, 2017
DEF 14A Proxy statement Mar 3, 2017 Mar 3, 2017
PRE 14A Preliminary proxy statement Jan 31, 2017 Jan 31, 2017
DEF 14A Proxy statement Apr 18, 2016 Apr 15, 2016
DEF 14A Proxy statement May 11, 2015 Jun 16, 2015
PRE 14A Preliminary proxy statement Apr 21, 2015 Apr 21, 2015
DEF 14A Proxy statement Apr 9, 2014 May 20, 2014
DEF 14A Proxy statement Apr 3, 2013 May 6, 2013
DEF 14A Proxy statement Mar 14, 2012 Apr 16, 2012
DEFA14A Additional proxy material Apr 5, 2011 —
DEFA14A Additional proxy material Apr 5, 2011 —
DEF 14A Proxy statement Mar 16, 2011 Apr 21, 2011
DEFA14A Additional proxy material Apr 28, 2010 —
DEFA14A Additional proxy material Apr 16, 2010 —
DEF 14A Proxy statement Apr 2, 2010 May 5, 2010
PRE 14A Preliminary proxy statement Mar 22, 2010 Mar 22, 2010
DEFA14A Additional proxy material Jun 2, 2009 —
DEFA14A Additional proxy material May 19, 2009 —
DEFA14A Additional proxy material May 18, 2009 —
DEFA14A Additional proxy material May 13, 2009 —
DEFA14A Additional proxy material May 12, 2009 —
DEFA14A Additional proxy material May 7, 2009 —
DEFA14A Additional proxy material May 5, 2009 —
DEFA14A Additional proxy material Apr 30, 2009 —
DEFA14A Additional proxy material Apr 16, 2009 —
DEF 14A Proxy statement Apr 2, 2009 May 20, 2009
DEF 14A Proxy statement Apr 4, 2008 Apr 4, 2008
DEF 14A Proxy statement Apr 17, 2007 May 22, 2007
DEF 14A Proxy statement May 1, 2006 May 1, 2006
DEF 14A Proxy statement May 2, 2005 Jun 28, 2005
DEF 14A Proxy statement Apr 29, 2004 Apr 29, 2004
DEF 14A Proxy statement Mar 31, 2003 Apr 30, 2003
DEF 14A Proxy statement Mar 26, 2002 May 1, 2002
DEF 14A Proxy statement Apr 2, 2001 May 4, 2001
DEF 14A Proxy statement Mar 31, 2000 Dec 31, 1999
DEF 14A Proxy statement Sep 14, 1999 Oct 15, 1999
PRE 14A Preliminary proxy statement Sep 1, 1999 Oct 15, 1999
DEF 14A Proxy statement Mar 23, 1999 May 7, 1999
DEF 14A Proxy statement Apr 3, 1998 Dec 31, 1997
DEF 14A Proxy statement Feb 24, 1997 Sep 30, 1996

Showing 55 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PRPH (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
868278
Former names
QUIGLEY CORP (until May 18, 2010)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.